A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR

A. Tosco,F. De Gregorio,Speranza Esposito,D. De Stefano,Ilenia Sana,Eleonora Ferrari,Angela Sepe,Laura Salvadori,P. Buonpensiero,A. Di Pasqua,R Grassia,C.A. Leone,Stefano Guido,G De Rosa,Sara Lusa,Gianni Bona,Gautier Stoll,Maria Chiara Maiuri,Anil Mehta,Guido Kroemer,Luigi Maiuri,Valeria Raia

A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR

2016

A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR

Keywords:

Cystic fibrosis
Epigallocatechin gallate
Molecular biology
Apoptosis
Programmed cell death
Autophagy
Cysteamine
Cystic fibrosis transmembrane conductance regulator
Immunology
Pharmacology
Cell growth
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations